Overpayment for Generic Drugs Under Medicare Part D
This cross-sectional study evaluates whether certain pharmacy benefit manager practices result in increased out-of-pocket costs for Medicare Part D beneficiaries.
Authors
- Inmaculada Hernandez (ORCID: https://orcid.org/0000-0002-0118-4986)
- Nico Gabriel (ORCID: https://orcid.org/0000-0003-1793-2245)
- Yashwant Pathak (ORCID: https://orcid.org/0000-0002-5251-4308)
- Ryan N. Hansen (ORCID: https://orcid.org/0000-0003-3887-1242)
- Sean D. Sullivan
Institutions
- University of Washington (US)
- West Health (US)
- University of California San Diego (US)
- University of Montana (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.0012
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13